Volume | 11,012,031 |
|
|||||
News | - | ||||||
Day High | 91.70 | Low High |
|||||
Day Low | 89.78 |
Company Name | Etf Ticker Symbol | Market | Type |
---|---|---|---|
SPDR S&P Biotech | XBI | AMEX | Exchange Traded Fund |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
90.98 | 89.78 | 91.70 | 89.98 | 88.34 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
122,654 | 11,012,031 | 90.39 | 995,415,330 | - | 63.80 - 103.52 |
Last Trade Time | Type | Quantity | Etf Price | Currency |
---|---|---|---|---|
20:00:00 | 230,667 | 89.98 | USD |
SPDR S&P Biotech (XBI) Options Flow Summary
SPDR S&P Biotech Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
6.97B | 77.43M | - | 18.32M | 733.48M | 9.47 | 9.50 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News SPDR S&P Biotech
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
XBI Historical
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 82.58 | 91.70 | 81.63 | 86.08 | 10,914,281 | 7.68 | 9.30% |
1 Month | 88.96 | 91.765 | 81.14 | 86.33 | 11,142,268 | 1.30 | 1.46% |
3 Months | 89.96 | 103.52 | 81.14 | 92.42 | 11,318,196 | 0.30 | 0.33% |
6 Months | 69.46 | 103.52 | 64.99 | 87.09 | 11,370,747 | 20.80 | 29.95% |
1 Year | 81.08 | 103.52 | 63.80 | 83.55 | 9,468,455 | 9.18 | 11.32% |
3 Years | 137.93 | 141.50 | 61.78 | 89.01 | 9,633,231 | -47.67 | -34.56% |
5 Years | 84.68 | 174.79 | 61.78 | 93.58 | 7,998,080 | 5.58 | 6.59% |
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI). |